ReviewFrontiers in oncology2022

Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factors.

Zhangguo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.